B. Baggio et al., Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis, KIDNEY INT, 58(3), 2000, pp. 1278-1284
Background. Reports of an increase in plasma and erythrocyte phospholipid a
rachidonic acid content and in urinary prostaglandin E-2 (PGE(2)) excretion
in patients with idiopathic calcium nephrolithiasis suggested their crucia
l role in the pathogenesis of hypercalciuria, a well-known risk factor for
lithogenesis.
Methods. To confirm this hypothesis, 15 healthy subjects and 20 nephrolithi
asis patients were evaluated for plasma phospholipid polyunsaturated fatty
acid content and PGE(2) concentration, serum parathyroid hormone, 25 hydrox
yvitamin D-3, 1,25-dihydroxyvitamin D-3, and bone-specific alkaline phospha
tase levels, as well as urinary excretion of calcium, biochemical markers o
f bone resorption (hydroxyproline and crossLaps), and intestinal calcium ab
sorption. Furthermore, the effect of a 30-day fish-oil diet supplementation
on the previously mentioned parameters was investigated in the patients.
Results. At baseline, patients compared with controls showed higher levels
of plasma phospholipid arachidonic acid content (P = 0.002). PGE(2) (P = 0.
0004), serum 25-vitamin D-3 (P = 0.001), and 1,25-vitamin D-3 (P = 0.001),
urinary excretion of calcium (P = 0.001), hydroxyproline (P = 0.007), and c
rossLaps (P = 0.019), as well as intestinal calcium absorption (P = 0.03 at
60 min). Fish oil supplementation induced a reduction in the plasma phosph
olipid arachidonic acid level (P < 0.0001), and except for serum concentrat
ions of 25-vitamin D-3, normalized baseline blood and urinary parameters, i
ncluding intestinal calcium absorption. A close correlation between plasma
PGE, and serum 1,25-vitamin D-3 (P = 0.004) and between phospholipid arachi
donic acid and intestinal calcium absorption (P = 0.0002) and calciuria (P
= 0.007) was observed, as well as between urine excretion of crossLaps and
hydroxyproline (P < 0.0001), crossLaps and calcium (P < 0.0001), and hydrox
yproline and calcium (P < 0.0001).
Conclusions. These findings indicate that the phospholipid arachidonic acid
content anomaly could represent the primary event responsible for the mosa
ic of metabolic and clinical alterations that are distinctive features of r
enal stone formers, and suggest that a common pathogenetic mechanism might
account for the several forms of hypercalciuria detected in idiopathic calc
ium nephrolithiasis.